Key Takeaways
- • Lionheart Ventures has closed $10 million in capital for its second fund, according to regulatory filings cited by Venture Capital Journal.
- • The firm's target fund size remains undisclosed, limiting visibility into the fund's ultimate capitalization and investment capacity.
- • Lionheart Ventures focuses on artificial intelligence, mental health technology, and impact-related companies, positioning itself at the intersection of technology and social outcomes.
- • The $10 million close represents an early-stage fundraise for Fund II, with no information on timeline to final close or whether additional capital commitments are outstanding.
Summary
Lionheart Ventures, a San Francisco-based venture capital firm, has raised $10 million for its second institutional fund, the firm announced via regulatory filing. The capital represents the firm's sophomore fund following an earlier fund structure, though the primary sources do not detail the size or performance of Fund I.
The venture firm specializes in three core investment verticals: artificial intelligence technologies, mental health technology platforms, and impact-related companies that generate both financial and social returns. This focus positions Lionheart within the broader venture ecosystem's shift toward thematic, mission-aligned investing alongside traditional venture returns.
A notable gap in the disclosed information is the absence of a target fund size. Regulatory filings confirm the $10 million capital raise, but no guidance has been provided on whether this represents the final close target, an interim milestone, or a partial commitment. This opacity is not uncommon in early-stage fund announcements, particularly for emerging or smaller venture vehicles that may still be in active fundraising cycles.
For institutional investors and family offices evaluating emerging venture managers, the limited disclosure underscores the importance of direct manager engagement to clarify fund strategy, deployment timelines, and overall capitalization plans. The firm's focused thesis on AI and mental health technology aligns with significant institutional capital deployment trends in 2025-2026, though investor appetite for early-stage venture remains selective given market conditions.
The venture firm specializes in three core investment verticals: artificial intelligence technologies, mental health technology platforms, and impact-related companies that generate both financial and social returns. This focus positions Lionheart within the broader venture ecosystem's shift toward thematic, mission-aligned investing alongside traditional venture returns.
A notable gap in the disclosed information is the absence of a target fund size. Regulatory filings confirm the $10 million capital raise, but no guidance has been provided on whether this represents the final close target, an interim milestone, or a partial commitment. This opacity is not uncommon in early-stage fund announcements, particularly for emerging or smaller venture vehicles that may still be in active fundraising cycles.
For institutional investors and family offices evaluating emerging venture managers, the limited disclosure underscores the importance of direct manager engagement to clarify fund strategy, deployment timelines, and overall capitalization plans. The firm's focused thesis on AI and mental health technology aligns with significant institutional capital deployment trends in 2025-2026, though investor appetite for early-stage venture remains selective given market conditions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.